Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article
Open Access

Effective anti-PD-1 therapy reduces neutrophil infiltration via T cell–macrophage chemokine axis in hepatocellular carcinoma

Jiahao Huang, Boyang Yi, Kuo Qi, Delin Ma, Feifei Sun, Bo Han, Yijie Zhao, Wuzhou Wan, Ning Zhang and Rong Liu
Cancer Biology & Medicine November 2026, 20260468; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0468
Jiahao Huang
1Translational Cancer Research Center, Peking University First Hospital, Beijing 100034, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boyang Yi
1Translational Cancer Research Center, Peking University First Hospital, Beijing 100034, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuo Qi
2Department of Orthopedics, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Delin Ma
3Department of Hepatobiliary Surgery, Peking University People’s Hospital, Beijing 100044, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feifei Sun
4Department of Pathology, Peking University People’s Hospital, Beijing 100044, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Han
4Department of Pathology, Peking University People’s Hospital, Beijing 100044, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yijie Zhao
5Department of Laboratory Animal Science, Peking University Health Science Center, Beijing 100191, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wuzhou Wan
6Yunnan Baiyao Group, Kunming 650504, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ning Zhang
1Translational Cancer Research Center, Peking University First Hospital, Beijing 100034, China
6Yunnan Baiyao Group, Kunming 650504, China
7Frontiers Science Center for Cancer Integrative Omics, International Cancer Institute, Peking University Health Science Center, Beijing 100191, China
8Department of Cell Biology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ning Zhang
  • For correspondence: zhangning{at}bjmu.edu.cn liurong{at}bjmu.edu.cn
Rong Liu
1Translational Cancer Research Center, Peking University First Hospital, Beijing 100034, China
9Southwest United Graduate School, Kunming 650092, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rong Liu
  • For correspondence: zhangning{at}bjmu.edu.cn liurong{at}bjmu.edu.cn
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

20260468
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2026.0468

Published By 
Cancer Biology & Medicine
History 
  • Received June 7, 2026
  • Accepted October 8, 2026
  • Published online November 4, 2026.

Article Versions

  • You are currently viewing a previous version of this article (November 4, 2026 - 06:40).
  • View the most recent version of this article
Copyright & Usage 
Copyright: © 2026, The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.

Author Information

  1. Jiahao Huang1,
  2. Boyang Yi1,
  3. Kuo Qi2,
  4. Delin Ma3,
  5. Feifei Sun4,
  6. Bo Han4,
  7. Yijie Zhao5,
  8. Wuzhou Wan6,
  9. Ning Zhang1,6,7,8⇑ and
  10. Rong Liu1,9⇑
  1. 1Translational Cancer Research Center, Peking University First Hospital, Beijing 100034, China
  2. 2Department of Orthopedics, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China
  3. 3Department of Hepatobiliary Surgery, Peking University People’s Hospital, Beijing 100044, China
  4. 4Department of Pathology, Peking University People’s Hospital, Beijing 100044, China
  5. 5Department of Laboratory Animal Science, Peking University Health Science Center, Beijing 100191, China
  6. 6Yunnan Baiyao Group, Kunming 650504, China
  7. 7Frontiers Science Center for Cancer Integrative Omics, International Cancer Institute, Peking University Health Science Center, Beijing 100191, China
  8. 8Department of Cell Biology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
  9. 9Southwest United Graduate School, Kunming 650092, China
  1. Correspondence to: Ning Zhang and Rong Liu, E-mail: zhangning{at}bjmu.edu.cn and liurong{at}bjmu.edu.cn
View Full Text

Funding

  • National Natural Science Foundation of China

    82588201
  • National Natural Science Foundation of China

    82030079
  • National Natural Science Foundation of China

    82341005 to NZ
  • National Natural Science Foundation of China

    82073270 to RL
  • National Key R&D Program of China (NKRDPC)

    2022YFC3400901 to NZ
  • Beijing Natural Science Foundation

    L2510036 to RL

This study was jointly supported by the National Natural Science Foundation of China (Grant Nos. 82588201, 82030079, and 82341005 to NZ, and Grant No. 82073270 to RL), National Key R&D Program of China (NKRDPC) (Grant No. 2022YFC3400901 to NZ), and Beijing Natural Science Foundation (Grant No. L2510036 to RL).

PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 23 (10)
Cancer Biology & Medicine
Vol. 23, Issue 10
15 Oct 2026
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effective anti-PD-1 therapy reduces neutrophil infiltration via T cell–macrophage chemokine axis in hepatocellular carcinoma
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Effective anti-PD-1 therapy reduces neutrophil infiltration via T cell–macrophage chemokine axis in hepatocellular carcinoma
Jiahao Huang, Boyang Yi, Kuo Qi, Delin Ma, Feifei Sun, Bo Han, Yijie Zhao, Wuzhou Wan, Ning Zhang, Rong Liu
Cancer Biology & Medicine Nov 2026, 20260468; DOI: 10.20892/j.issn.2095-3941.2026.0468

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effective anti-PD-1 therapy reduces neutrophil infiltration via T cell–macrophage chemokine axis in hepatocellular carcinoma
Jiahao Huang, Boyang Yi, Kuo Qi, Delin Ma, Feifei Sun, Bo Han, Yijie Zhao, Wuzhou Wan, Ning Zhang, Rong Liu
Cancer Biology & Medicine Nov 2026, 20260468; DOI: 10.20892/j.issn.2095-3941.2026.0468
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Supporting Information
    • Conflict of interest statement
    • Author contributions
    • Data availability statement
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Thermal ablation versus loop electrosurgical excision procedure and cold knife conization for cervical intraepithelial neoplasia: efficacy and HPV clearance in a 5-year cohort of Chinese women
  • VAMP2/SNAP25 promotes the aggressive progression of head and neck cancer by regulating the fate of multivesicular bodies
Show more Original Article

Similar Articles

Keywords

  • Hepatocellular carcinoma
  • immunotherapy
  • tumor-associated macrophage
  • tumor-associated neutrophil
  • tumor-infiltrating lymphocyte

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire